I’ve been writing regular psychedelic news weekly link roundups and monthly/yearly recaps for more than 7.5 years (all the while without missing a single week) and today I’m announcing that they are coming to an end. Here's why. https://t.co/U3kxM5MFIE
@mapsofthemind Thanks John! I've greatly appreciated your support over the years. Hope you're having a wonderful 2023 so far and I am looking forward to seeing what's next too. 🙂
I’ve been writing regular psychedelic news weekly link roundups and monthly/yearly recaps for more than 7.5 years (all the while without missing a single week) and today I’m announcing that they are coming to an end. Here's why. https://t.co/U3kxM5MFIE
@Josh__Hardman Thanks so much Josh! I appreciate your support and glad you got value out of my work. Hope you continue to keep it up on your end because I've enjoyed reading Psychedelic Alpha a lot too. 😃
This Month in Psychedelics: Brittney Griner came home, MAPS was found liable in a wrongful death lawsuit, a batch of hallucinogenic spinach was recalled, and a look ahead at cannabis and psychedelic drug reform possibilities in 2023. https://t.co/V1Umj33tm2
Heads up—you can get $15 off on my friend @mapsofthemind's "Facilitating Psychedelic Experiences" workshop this Sunday by using the promo code WILDER15, which brings the total amount down to $50 (from $65). More info here: https://t.co/sy7zZEWdpy
This Month in Psychedelics: Many U.S. drug policy reform efforts succeeded during the midterm elections, a shroom dispensary opened in Florida, two big research studies are over, and the National Park Service politely asked visitors to not lick the toads. https://t.co/xbs1SnbF62
This Month in Psychedelics: MAPS is preparing for a wrongful death lawsuit, Canada and Germany are slated to loosen their approaches to drug policy, new research on MDMA for eating disorders, & two major losses in cannabis and psychedelic criminal cases. https://t.co/iuLht8zPt0
new: why does THC make it hard to form short-term memories? scientists have theories, but no one knows for sure. here's what we know so far, with a light intro into partial agonists, glutamate and the hippocampus
https://t.co/AYmFiNNfc4